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Abstract 
Cell-laden hydrogels whose crosslinking density can be dynamically and reversibly 
tuned are highly sought-after for studying pathophysiological cellular fate processes, including 
embryogenesis, fibrosis, and tumorigenesis. Special efforts have focused on controlling network 
crosslinking in poly(ethylene glycol) (PEG) based hydrogels to evaluate the impact of matrix 
mechanics on cell proliferation, morphogenesis, and differentiation. In this study, we sought to 
design dynamic PEG-peptide hydrogels that permit cyclic/reversible stiffening and softening. 
This was achieved by utilizing reversible enzymatic reactions that afford specificity, 
biorthogonality, and predictable reaction kinetics. To that end, we prepared PEG-peptide 
conjugates to enable sortase A (SrtA) induced tunable hydrogel crosslinking independent of 
macromer contents. Uniquely, these hydrogels can be completely degraded by the same 
enzymatic reactions and the degradation rate can be tuned from hours to days. We further 
synthesized SrtA-sensitive peptide linker (i.e., KCLPRTGCK) for crosslinking with 8-arm PEG-
norbornene (PEG8NB) via thiol-norbornene photocrosslinking. These hydrogels afford diverse 
softening paradigms through control of network structures during crosslinking or by adjusting 
enzymatic parameters during on-demand softening. Importantly, user-controlled hydrogel 
softening promoted spreading of human mesenchymal stem cells (hMSCs) in 3D. Finally, we 
designed a bis-cysteine-bearing linear peptide flanked with SrtA substrates at the peptide’s N- 
and C-termini (i.e., NH2-GGGCKGGGKCLPRTG-CONH2) to enable cyclic/reversible hydrogel 
stiffening/softening. We show that matrix stiffening and softening play a crucial role in growth 
and chemoresistance in pancreatic cancer cells. These results represent the first dynamic 
hydrogel platform that affords cyclic gel stiffening/softening based on reversible enzymatic 
reactions. More importantly, the chemical motifs that affords such reversible crosslinking were 
built-in on the linear peptide crosslinker without any post-synthesis modification. 
Keywords: Sortase A; dynamic hydrogels; extracellular matrix; cancer; tissue stiffening   
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1. Introduction  
Stiffening and softening of extracellular matrix (ECM) contribute to many biological 
processes including cancer progression, stem cell differentiation, and tissue fibrosis [1-3]. 
Specifically, mechanical properties of ECM affect changes in cellular morphologies [4, 5], 
protein expression and secretion [6], and stem cell differentiation potentials [7, 8]. For example, 
matrix stiffening has been shown to promote aggressive phenotypes, epithelial-to-mesenchymal 
transition (EMT), and chemo-resistance in pancreatic ductal adenocarcinoma (PDAC) [1, 9]. On 
the molecular level, prior studies have established a causal link between matrix stiffness and 
nuclear localization of yes-associated protein (YAP). In particular, Rice and colleagues reported 
that increasing matrix stiffness (~1 kPa to ~4 kPa) lead to an increase in YAP nuclear 
localization in three different pancreatic cancer cell lines [9]. Nguyen and colleagues identified 
higher matrix moduli (~3 kPa) promoted metastatic potential of PDAC cell lines [10]. On the 
other hand, matrix softening was shown to reduce sensitivity of myeloid leukemia subtypes to 
chemotherapeutics [11]. ECM biophysical stimuli also affect morphology and differentiation 
potentials of human mesenchymal stem cells (hMSCs). Discher and colleagues demonstrated 
that culturing hMSCs on soft (0.1-1kPa) substrates yielded cellular morphology akin to 
neurogenic lineage, whereas stiffer substrate (25-40 kPa) promoted osteogenic differentiation 
[12].  
Cell fate processes have been increasingly studied using cell-laden three-dimensional 
(3D) hydrogels. However, hydrogels with static mechanical properties may not fully recapitulate 
the dynamic nature of tissue mechanics [13-20] and few 3D culture materials permit user-
initiated control over matrix physiochemical properties [21-23]. Recent efforts on ‘dynamic’ 
hydrogels have allowed researchers to control matrix stiffening and/or softening patterns that 
mimic the ever-changing ECM microenvironment. ‘Stiffening’ hydrogels are often designed to 
permit secondary crosslinking upon exposure to external stimuli such as light, temperature, pH, 
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or enzymes. On the other hand, hydrolytic [24-26] or enzymatic cleavage [27, 28] are typically 
utilized to soften matrices without user intervention. User-controlled matrix softening can be 
achieved through the addition of photoresponsive linkers [29]. For example, Anseth and 
colleagues developed elegant photodegradable hydrogels that permit the investigation of local 
matrix softening on cell behaviors [29]. Rosales et al. [14, 19], Zheng et al. [15], and Lee et al. 
[18] fabricated hydrogels with photoswitchable azobenzene moieties that afford reversible 
control of stiffness. Reversible tuning of matrix stiffness is achieved upon irradiation with the 
appropriate wavelength of light. In another example, controlling diol and boronic acid reactivity 
through azobenzene cis-trans transition was implemented to dynamically stiffen hydrogels [16]. 
Our group has also utilized supramolecular host-guest interactions to reversibly stiffen and 
soften hydrogels [17].  
The above examples highlight the importance of creating a hydrogel network with 
reversible stiffening/softening capability. To this end, enzymatic reactions can afford substrate 
specificity and mild/predictable reaction kinetics [23, 30-36]. Our lab has previously utilized 
mushroom tyrosinase (MT) to dynamically stiffen hydrogels containing either tyrosine residues 
[23, 36] or 4-hydroxyphenyl acetic acid (HPA) [35]. We have also reported the design of PEG-
peptide hydrogels that were sensitive to both MT and sortase A (SrtA). The hydrogels were 
susceptible to orthogonal and enzymatic control of crosslinking and on-demand stiffening [36]. 
While MT-mediated tyrosine dimerization affords efficient stiffening regimes, this enzymatic 
reaction is limited by the availability of dissolved molecular oxygen, the irreversibility of the di-
tyrosine products, and unexpected oxidation of tyrosine-rich proteins. These disadvantages 
could be circumvented by using SrtA, a cysteine transpeptidase highly useful in site-specific 
protein labeling [37-41], peptide cyclization [42-46], and antibody modification [47-51]. 
Mechanistically, SrtA cleaves the amide bond between threonine and glycine residues of the 
LPXTG (where X is any amino acid except proline) sequence, resulting in a thiol-acyl 
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intermediate that is subsequently resolved by an oligoglycine substrate (Gn). The end product of 
this enzymatic reaction is a new peptide sequence LPXT(Gn) (Fig. 1A) that itself serves as a 
substrate for further SrtA transpeptidation. Of note, this reaction is also susceptible to 
hydrolysis, resulting in the formation of an unreactive pendant LPRT-OH [52]. Nonetheless, this 
biorthogonal enzymatic reaction can be utilized to crosslink, degrade, and modify hydrogels by 
incorporating the peptide substrates into the super structure of the hydrogels. Specifically, the 
LPXTG and Gn peptides can be tethered to macromers using either Michael-type addition [53, 
54] or thiol-norbornene click chemistry [36]. Upon addition of SrtA, the peptides are ligated to 
create new crosslinks. Broguire et al. recently reported the use of SrtA to crosslink hyaluronic 
acid-based hydrogels for tissue engineering applications [53]. In another example, Griffith and 
colleagues incorporated SrtA-labile LPXTG substrate as part of the linkers in hydrogels formed 
by either Michael-type or thiol-norbornene chemistry [54]. Addition of SrtA and soluble glycine 
led to breakage of the LPETG peptide, eventually resulted in degradation of the hydrogels.  
In this work, we attempt to expand the utility of SrtA-mediated transpeptidation to: (1) 
control hydrogel crosslinking and degradation; (2) permit controllable degrees of hydrogel 
softening; and (3) enable reversible stiffening and softening of PEG-peptide hydrogels. We used 
a hepta-mutant variant of SrtA for its increased catalytic activity and calcium-independency [39, 
55, 56]. We designed simple linear peptide linkers containing SrtA-specific sequences to afford 
rapid and controllable crosslinking of PEG-peptide hydrogels. These gels can be 
dissolved/degraded within hours to days. We also used a SrtA-sensitive peptide crosslinker to 
afford controllable softening and the matrix was leveraged to control spreading of hMSCs in 3D. 
Finally, we designed a linear bis-cysteine peptide crosslinker whose N- and C-terminus was 
flanked with the two SrtA substrates to demonstrate cyclic/reversible hydrogel stiffening and 
softening. Most importantly, this dynamic cell culture platform was exploited for studying 
stiffness-dependent growth and chemo-resistance in pancreatic cancer cells (PCCs). 
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2. Materials & Methods 
2.1 Materials 
Eight-arm PEG-OH (20 kDa) was acquired from JenKem Technology, USA. 5-
Norbornene-2-carboxylic acid, N,N-dicyclohexylcarbodiimide (DCC), 4-(dimethylamino)pyridine 
(DMAP), dimethyl phenylphosphonite, 2,4,6-trimethylbenzoyl chloride, 2-butanone, lithium 
bromide, diethyl ether, and Isopropyl-D-1 thogalactopyranoside (IPTG) were obtained from 
Sigma-Aldrich. Fmoc-protected amino acids N,N,N,N -tetramethyl-O-(1H-benzotriazol-1-
yl)uranium hexafluorphosphate (HBTU), and hydroxybenzotriazole (HOBt) were purchased from 
Anaspec. BL21 Escherichia coli (E. coli) was purchased from New England Biolabs. Kanamycin 
sulfate was obtained from IBI Scientific. Lysogeny broth, Lennox formulation, agar and broth 
were obtained from DOT Scientific. Gemcitabine was obtained from TSZ CHEM. Mammalian 
cell Live/Dead staining kit was obtained from Life Technologies Corp. All other chemicals were 
obtained from Fisher Scientific unless otherwise noted. 
2.2 Macromer and peptide synthesis 
Eight arm PEG-norbornene (PEG8NB, ~95% substitution) and photoinitiator lithium aryl 
phosphinate (LAP) were synthesized as described previously [36, 57]. Peptides were 
synthesized in an automated microwave-assisted peptide synthesizer (Liberty 1, CEM). Crude 
peptides bound to resin were reacted with a solution containing 95% trifluoroacetic acid (TFA), 
2.5% ddH2O, 2.5% triisopropylsilane (TIS), and 5% (w/v) phenol for 3 hours at room 
temperature for cleavage. Immediately following cleavage, the peptides were precipitated in 
cold ethyl ether. Dried, crude peptides were purified using High-Performance Liquid 
Chromatography (HPLC, Flexar System, Perkin Elmer). Purified peptides were lyophilized and 
their masses confirmed via mass spectrometry (Agilent Technologies). All peptides were stored 
at -20oC prior to use. 
2.3 Heptamutant SrtA expression and purification 
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Heptamutant SrtA (P94R, E105K, E108Q, D160N, D165A, K190E, K196T) was 
expressed and purified as described previously [36, 58]. Competent BL21 E. coli were 
transformed with pet30b-7M SrtA plasmid (a gift from Hidde Ploegh. Addgene plasmid #51141) 
and grown on an LB-agar selection plate containing kanamycin (30 µg/mL). Individual colonies 
were inoculated in 10 mL of LB broth supplemented with kanamycin (30 µg/mL). After overnight 
shaking (220 rpm, 37 oC), the cultures were diluted 100-fold in LB media supplemented with 
kanamycin and placed on an orbital shaker (220 rpm at 37 oC), and the optical density at 600 
nm (OD600) was monitored. SrtA expression was induced at OD600 = 0.4-0.6 by adding IPTG 
(400 µM) to the cultures and shaking for 3 hours at 37 oC and 220 rpm. Following induction, the 
cell pellets were isolated by centrifugation (8000 rpm, 15 minutes) and stored at -80 oC prior to 
lysis. Cell lysis was performed by suspending the pellets in lysis buffer (20 mM Tris, 50 mM 
NaCl, 0.2 mg/mL lysozyme, 1x Halt EDTA-free protease inhibitor cocktail, and DNase I). 
Following a 30-minute incubation at 4 oC, the suspended pellets were subject to sonication (2 
cycles of 3 minutes with 30% duty cycle, 20% amplitude followed by a 3-minute cool-down 
period). Lysates were clarified by centrifugation (10000 x g, 20 min, 4 oC) and purified via His60 
Ni Superflow resin and columns per manufacturer’s protocol. Purified SrtA (~40 mg/L of culture) 
was concentrated with Ultra-15 Centrifugal Filter Units (3 kDa MWCO, Amicon) and desalted 
with Zeba Spin desalting columns (7 kDa MWCO, Thermo Fisher Scientific). The enzyme in 
PBS (pH = 7.4) was aliquoted, flash frozen, and stored at -80 oC Stock concentrations of SrtA 
were obtained by Ellman’s assay measuring the free sulfhydryl on SrtA. Typical concentrations 
of SrtA stock aliquots were ~4 mM. 
2.4 Sortase A-mediated hydrogel crosslinking and degradation 
PEG-peptide conjugates (i.e., PEG-GGGG and PEG-LPRTG) were prepared by reacting 
free norbornene groups of PEG8NB with cysteine-bearing peptides via thiol-norbornene 
photoclick chemistry. GGGGC or LPRTGC peptides were separately dissolved in PBS (pH = 
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7.4) prior to quantification of their concentrations with Ellman’s assay. To a round bottom flask, 
PEG8NB, peptides (1.5-fold excess to norbornene moieties), and photoinitiator LAP (5 mM) 
were added. The conjugation of peptide to PEG8NB was initiated upon exposure to light 
(Omnicure s1000, 365 nm, 40 mW/cm2) for 30 minutes. Additional LAP was added at 15 
minutes to improve conjugation efficiency. The PEG-peptide conjugates were dialyzed against 
ddH2O for 2 days to remove residual peptides and LAP. Using TNBSA assay, we determined 
the amine group concentration of the PEG-GGGG conjugate (~2.66 mM/wt% of PEG-GGG). 
Note that the PEG-peptide conjugates can also be prepared by Michael-type reaction between 
cysteine-bearing peptides and multi-arm PEG-vinylsulfone or PEG-maleimide. It is also worth 
noting that the cysteine residue at the active site of SrtA is not reactive towards norbornene 
groups as the thiol-norbornene reaction only occurs under radical-mediated light exposure. The 
purified conjugates were lyophilized and stored at -20oC prior to use. 
To initiate gelation, PEG-peptide conjugates were mixed in the presence of SrtA and 
immediately injected between glass slides separated by 1 mm Teflon spacers. After 10 minutes 
of gelation, the hydrogels were transferred to a 24-well plate containing PBS. The hydrogels 
were washed three times with PBS (30 min per wash) to remove residual SrtA and incubated at 
37oC for 16 hours prior to degradation studies. After SrtA-mediated gelation, the initial masses 
(Wo) of the hydrogels were measured, followed by placing the hydrogels in buffer solution 
containing specified concentrations of: (1) SrtA with soluble glycinamide for transpeptidation-
mediated degradation, or (2) SrtA alone for hydrolytic degradation. At specified time points, the 
hydrogels were removed from the degradation buffers, blotted dry, weighed (W t), and returned 
to solution. This process was repeated until the hydrogels were fully degraded. For the 
hydrolytic degradation, fresh SrtA-containing buffer was exchanged after 24 hours of incubation. 
The results were presented as: Mass loss (%) = 100% × (Wt-W0)/W0. 
2.5 Thiol-norbornene photopolymerization of SrtA-responsive hydrogels 
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 For experiments related to tuning matrix stiffening and softening, hydrogels were 
fabricated by reacting PEG8NB and bis-cysteine containing peptides (e.g., KC-LPRTG-CK, KC-
LPRTA-CK, or GGG-CKGGGKC-LPRTG) via thiol-norbornene photoclick chemistry. Briefly, 
PEG8NB and peptides were mixed at a stoichiometric ratio of thiol to norbornene along with 
photoinitiator LAP (1 mM). The precursor solution with pre-defined compositions was injected 
between two glass slides separated by 1 mm Teflon spacers, followed by exposure to 365 nm 
light (5 mW/cm2) for 2 minutes. The obtained hydrogels were swollen for 16 hours in PBS prior 
to dynamic stiffening or softening.  
2.6 Sortase A-mediated hydrogel softening & stiffening 
Controlled softening of PEG-peptide hydrogels was achieved by incubating the swollen 
gels in buffer solution containing specified concentrations of SrtA and oligoglycine substrate 
(GGGGC, glycinamide, etc.). Storage moduli of the gels were measured before softening and at 
specified time points during, and after softening using oscillatory rheometry in strain sweep 
mode (8 mm parallel plate geometry, 0.1% to 5% strain at 1 Hz frequency).  
 Swollen hydrogels were incubated with solutions containing either SrtA or SrtA with 
soluble glycine to induce stiffening or softening, respectively. After each incubation step, SrtA or 
SrtA with soluble glycine buffers were replaced with phosphate-buffered saline solution (PBS, 
pH = 7.4) after incubation to remove residual SrtA.  Storage moduli were measured prior to and 
after stiffening or softening. The gap sizes were reduced from 750 to 500 µm for stiffening and 
increased to 650 µm after softening due to observed volumetric shrinkage or swelling. 
2.7 Cell culture and encapsulation 
Human mesenchymal stem cells were maintained in low glucose Dulbecco’s Modified 
Eagle’s Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1 ng/mL basic 
fibroblast growth factor (bFGF), and 1x-penicillin streptomycin. Briefly bFGF was supplemented 
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in the media at 1 ng/mL as the concentration has been shown to maintain viability and 
proliferation of hMSCs during in vitro culture [59]. Media was refreshed every 2-3 days. PDAC 
cell line COLO-357 were maintained in high glucose DMEM supplemented with 10% FBS and 
1x-penicillin streptomycin. For encapsulation, hMSCs and COLO-357 cells were rinsed with 
Dulbecco’s phosphate-buffered saline (DPBS), trypsinized, counted via hemocytometry, and 
resuspended at specified cell density in DPBS. The cells were mixed with sterile-filtered (0.2 
µm) pre-polymer solutions containing PEG8NB, peptide crosslinkers (KCLPRTGCK, 
KCLPRTACK, or GGG-CKGGGKC-LPRTG), and LAP (1 mM). The solution was mixed and 
pipetted into a 1 mL syringe with cut-open tip. Cell-laden gels were cast upon exposure to 365 
nm light (5 mW/cm2) for 2 minutes and placed in a 24-well plate with fresh media. For the hMSC 
study, 3.5 wt% PEG-peptide gels were crosslinked with: (1) MMP-labile crosslinks 
(KCGPQG↑IWGQCK) for cell-mediated local degradation, (2) pendant CRGDS (1 mM) for cell 
adhesion, and (3) ‘G’ peptide linkage for SrtA-mediated softening (‘A’ peptide was used as 
control).  
2.8 Softening of hMSC-laden hydrogels 
Following encapsulation, hMSC-laden hydrogels were cultured in media for 7 days prior 
to SrtA-induced softening. Media was refreshed every 2-3 days. Softening was achieved 
through incubation of hydrogels in media containing 25 µM SrtA and 12 mM glycinamide for 4 
hours on day 7 post-encapsulation. Gels were subsequently washed with fresh media for 4 
hours to remove SrtA and glycinamide. Live/dead staining and confocal microscopy imaging 
were performed on day 1, 7, and 14 post-encapsulation to assess cell viability and morphology. 
At least three z-stacked images per gel (10 slices, 100 µm thick) were taken. F-actin and DAPI 
staining and confocal imaging were performed on day 14 post-encapsulation for assessing 
cytoskeletal structure and cell morphology. Circularity and average cell area values were 
measured using ImageJ software and the F-actin/DAPI stained confocal images. Circularity is 
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quantified as    
    
          
  and the area was quantified using the “Analyze Particles” function in 
ImageJ. 
2.9 Reversible stiffening of COLO-357-laden hydrogels and related assays 
 COLO-357-laden hydrogels (2.5 wt% PEG8NB) were incubated in media for 7 days prior 
to matrix stiffening. Static controls include soft (2.5 wt% PEG8NB) and stiff (3.5 wt% PEG8NB) 
hydrogels that were not responsive to SrtA treatment. To induce matrix stiffening, hydrogels 
were placed in media supplemented with 50 µM of SrtA and incubated for 4 hours. On day 14 
post-encapsulation, the hydrogels were placed in media with 50 µM of SrtA and 15 mM of 
soluble glycine substrate to induce softening. Live/dead staining and confocal microscopy 
imaging were performed on day 1, 7, 14, and 21 to assess cell viability and spheroid 
morphology. The spheroid diameters were measured using Nikon NIS-element software. 
 For the gemcitabine treatment study, COLO-357 cells were allowed to grow into 
spheroids for 4 days prior to SrtA-induced stiffening (50 µM, 4 hours). On day 7, hydrogels were 
treated with SrtA (50 µM) and glycinamide (15 mM) to induce softening. On day 10, these 
‘softened’ cell-laden hydrogels were treated with gemcitabine (1 µM) for 3 additional days prior 
to live/dead staining and imaging on day 13. Control groups include cell-laden hydrogels that 
only went through stiffening (i.e., Stiffened group), non-dynamic soft (i.e., Soft group. G’ ~ 1 
kPa), and non-dynamic stiff (i.e., Stiff group. G’ ~ 3 kPa). Metabolic activity was assessed via 
AlamarBlue reagent before and after gemcitabine treatment. Viability and spheroid morphology 
were monitored via live/dead staining and confocal imaging as described above.  
2.10 Statistical analysis 
 A two-way analysis of variance (ANOVA) with a Bonferroni post-hoc test to evaluate 
significance between experimental groups. For spheroid diameter experiments, two-way 
ANOVA was performed on the average diameter between three values from independent 
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experiments with three time points (i.e., day 7, day 14, and day 21). Single, double, and triple 
asterisks represent p < 0.05, 0.01, 0.001, respectively. All experiments were completed 
independently thrice. Quantitative results are presented as mean ± SEM. 
3.   Results 
3.1 SrtA-mediated crosslinking of PEG-peptide hydrogels 
 In order to exploit SrtA-initiated transpeptidation (Fig. 1A) for crosslinking of PEG-
peptide hydrogels, we conjugated PEG8NB macromers with cysteine-bearing SrtA substrates 
(i.e., NH2-GGGGC-NH2 and NH2-CLPRTG-NH2) via thiol-norbornene photoclick chemistry. 
Notably, the substitution of the peptide conjugate was approximately 70% as measured by 
TNBSA assay. In addition to the inherent limitation on peptide conjugation efficiency, it is also 
possible that some peptides were ‘damaged’ during the conjugation process. However, we 
showed that the resulting PEG-peptide conjugates were still functional and could be used to 
crosslink hydrogels using SrtA-initiated transpeptidation (Fig. 1B). At a fixed total PEG-peptide 
macromer content (6 wt%), gelation speed could be independently tuned from 10 minutes with 
300 M SrtA to 90 minutes with 50 M SrtA (Fig. 1C).  
3.2 SrtA-mediated hydrolytic degradation of SrtA-crosslinked PEG-peptide hydrogels 
 The reversibility of SrtA-mediated transpeptidation affords control not only in hydrogel 
crosslinking, but also in temporal degradation of PEG-peptide hydrogels. Specifically, hydrogels 
were degraded on-demand through addition of SrtA and soluble glycine substrates (e.g., 
glycinamide), which induce transpeptidation-based degradation (Fig. 1A). As concentrations of 
SrtA or glycinamide increased, gel degradation occurred significantly faster (Figs. 2A and 2B), 
as supported by the initial swelling (i.e., negative loss of mass) and then rapid mass loss of the 
gels. Complete degradation was achieved in approximately 5, 7, and 9 hours using 50, 25, and 
10 µM of SrtA, respectively. At a fixed SrtA concentration (e.g., 25 µM), hydrogels treated with 
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16 or 48 mM of glycinamide (i.e., 1- and 3-fold to crosslinker concentration in hydrogels) 
degraded completely in 7 or 5 hours, respectively.  
Incubation of hydrogels with SrtA alone permits slow hydrolytic degradation as water can 
react with the thioacyl intermediate to yield LPRT-OH (Fig. 1A) [52]. Compared with 
transpeptidation-mediated degradation, hydrolytic degradation occurs more slowly and has a 
nearly linear mass loss profiles (Fig. 2C). The hydrogels degraded in approximately 50 to 58 
hours when using only 50 to 25 µM of SrtA (i.e., without glycinamide), respectively.  
3.3 SrtA-mediated softening of thiol-norbornene PEG-peptide hydrogels 
 SrtA-initiated transpeptidation provides a high degree of control in crosslinking PEG-
peptide conjugates into hydrogels. However, it is challenging to use this enzymatic reaction and 
hydrogel design to achieve controlled gel softening owing to the erosion of gel surface and 
mass loss upon encountering the enzyme. We hypothesized that a different PEG-peptide 
hydrogel architecture could prevent gel mass loss while permitting SrtA-mediated on-demand 
softening. To achieve this, we synthesized bis-cysteine peptides sensitive (KCLPRTGCK, “G” 
peptide) or insensitive (KCLPRTACK, “A” peptide) to SrtA-mediated transpeptidation. Cysteine 
residues were added to afford thiol-norbornene photo-click gelation between macromer 
PEG8NB with “G” and/or “A” peptides, whereas lysine residues were added to improve the 
solubility of the peptides. Upon incubation in a solution containing SrtA and an oligoglycine 
substrate, only SrtA-sensitive linkages (i.e., G peptide) underwent cleavage (Fig. 3A). Varying 
the concentrations of A and G crosslinkers within 3 wt% PEG8NB-peptide hydrogels resulted in 
tunable degrees of SrtA-induced gel softening (Fig. 3B). Specifically, A:G ratios of 100%:0%, 
75%:25%, and 50%:50% respectively yielded 0-, 0.5-, and 0.75-fold moduli decrease compared 
with the initial modulus (G’o). Next, we investigated the role of SrtA concentration on softening 
time (3 wt% PEG, A:G ratio = 50%:50%). Above 25 µM SrtA, there was no notable difference in 
softening time, but hydrogels incubated with only 10 µM SrtA were degraded in a slower rate 
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(Fig. 3C). Furthermore, hydrogels formed with 2.5, 3, or 3.5 wt% of PEG showed increasing 
initial moduli (~0.75, ~2.5 or ~3 kPa, respectively), which were softened upon SrtA treatment to 
0.15, 0.75, or 1 kPa, respectively (Fig. 3D). In addition, hydrogels incubated in SrtA/oligoglycine 
substrate solution for 0.5, 2.5, and 4 hours softened to approximately 0.75, 0.5, and 0.2-fold of 
the initial modulus (Fig. 3E). 
While hydrogels crosslinked with SrtA-sensitive peptide (i.e., LPRTG) permitted 
controlled softening, attempts to re-stiffen these softened gels yielded disappointing results. 
Specifically, the hydrogels could only be re-stiffened to about 20% of the original gel moduli 
(data not shown). This was likely due to the difficulty for the infused SrtA to ‘reach’ the ‘broken’ 
peptides simultaneously in a highly swollen hydrogel. 
3.4 SrtA-mediated softening of hMSC-laden PEG-peptide hydrogels 
 The SrtA-induced softening hydrogels were used as a cell culture platform to evaluate 
the effect of temporal matrix softening on hMSCs spreading. In this study, hMSCs were 
encapsulated in hydrogels formed by 3.5 wt% PEG8NB with MMP-labile crosslinks 
(KCGPQG↑IWGQCK, for cell-mediated local degradation) and ‘G’ peptide linkage for SrtA-
mediated softening (‘A’ peptide was used as control). Note that all cell-laden hydrogels also 
contained 1 mM CRGDS for promoting cell adhesion. Furthermore, peptide crosslinkers were 
mixed at 40% SrtA-responsive ‘G’ peptide (or SrtA insensitive ‘A’ peptide) and 60% MMP-
sensitive peptide linker. Live/dead and F-actin/DAPI staining results showed that cells in both 
groups displayed mostly non-spreading morphology prior to SrtA-induced softening on day 7 
(Fig. 4A). Note that a higher initial gel stiffness (G’0 ~ 4 kPa) was used to demonstrate the effect 
of SrtA-mediated on-demand gel softening on cell fate processes. The high initial gel stiffness 
may be the reason causing noticeable number of dead cells on Day 1. By day 14, cells within 
the on-demand softened hydrogels adopted long and thin protrusions compared with cells 
encapsulated within statically stiff hydrogels. Semi-quantitative analysis of cell spreading 
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revealed a significant reduction in circularity (Fig. 4B) and increase in cell area (Fig. 4C) in cells 
experienced on-demand softening.  
3.5 Reversible stiffening of PEG-peptide hydrogels 
 Owing to its unique reversibility in peptide conjugation, we hypothesized that SrtA can be 
used to create hydrogels with dynamically and reversibly tunable stiffness. We designed a linear 
peptide flanked with the two SrtA substrates (GGG-CGGGC-LPRTG) for crosslinking into 
hydrogels via thiol-norbornene photopolymerization. The N-terminal GGG and C-terminal 
LPRTG sequences became pendant motifs permitting SrtA-mediated secondary crosslinking 
and degradation, thus leading to cyclic/reversible hydrogel stiffening and softening (Fig. 5A). To 
optimize SrtA-mediated matrix stiffening, PEG-peptide hydrogels (2.5 wt%) were incubated with 
varying time and concentrations of SrtA. A 1.75- to 2.5-fold increase in gel modulus (G’0 = 1 
kPa) were observed upon 3 hours of incubation with 25 µM of SrtA (Fig. 5B). Furthermore, 2- to 
4-fold increases in moduli were observed when 10 to 50 µM of SrtA were added for 4 hours 
(Fig. 5C). 
 The stiffened hydrogels could be further softened by incubating the hydrogels with SrtA 
alone or with SrtA and soluble glycine substrate. As shown in Figure 5D, moduli of the stiffened 
gels (G’stiff ~3 kPa) were decreased 0.8 to 0.5-fold with increasing concentrations of 
glycinamide, where maximum softening was achieved with 15 mM of soluble glycinamide and 
25 µM of SrtA. SrtA-mediated hydrolytic degradation could also be utilized to soften hydrogels at 
a slower rate (Fig. 5E). For example, hydrogels incubated with SrtA alone (25 µM) were 
softened to approximately 0.4-fold of the initial gel modulus. Finally, multiple cycles of reversible 
gel stiffening/softening could be achieved by incubating hydrogels alternatively with SrtA (for 
stiffening) and SrtA and soluble glycinamide (for softening) (Figure 6).   
3.6 Effect of stiffening and softening on COLO-357 viability and spheroid formation 
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 To demonstrate the feasibility of using SrtA-mediated reversible stiffening hydrogels as a 
platform for investigating cell fate processes, COLO-357 cells were encapsulated in SrtA-
sensitive hydrogels and exposed to stiffening and softening conditions. Cell-laden soft (2.5 wt% 
PEG8NB, G’ ~ 1 kPa) and stiff (3.5 wt% PEG8NB, G’ ~ 3 kPa) hydrogels were utilized as 
controls (i.e., without dynamic stiffening). Dynamically-stiffened PEG-peptide hydrogels (2.5 
wt% PEG8NB) formed with pendant SrtA substrates (i.e., GGG-CGGGC-LPRTG) were stiffened 
on day 7 and softened on day 14 (Fig. 7A). Per the confocal images, both the initial thiol-
norbornene gel crosslinking and SrtA-mediated stiffening/softening were cytocompatible as 
indicated by the high cell viability (Fig. 7B). We quantified diameters of the cell spheroids and 
found that when cultured in ‘statically soft’ hydrogels, the spheroid sizes grew steadily from ~40 
µm to ~51 µm over 21 days (Fig. 7C, Table 1). On the other hand, the growth was significantly 
hindered in cells maintained in ‘statically stiff’ hydrogels (Fig. 7D, Table 1). In the dynamic 
hydrogel group (i.e., Soft-Stiff-Soft), the growth of spheroids was initially delayed following 
stiffening (from D7 to D14). Subsequent softening of the hydrogels allowed the cell spheroids to 
grow again (Fig. 7E, Table 1). The patterns of spheroid size changes in the ‘Soft-Stiff-Soft’ 
hydrogels demonstrate the effect of dynamic matrix stiffening/softening on PCC growth.  
Table 1. Summary of average spheroid diameters in Figure 7.  
Day Soft (µm) Soft-Stiff-Soft (µm) Stiff (µm) 
7 40.08 ± 0.75ab 40.76 ± 0.76c 34.07 ± 0.84 
14 48.45 ± 3.30a 39.60 ± 1.84d 33.85 ± 0.35 
21 51.36 ± 2.77b 47.89 ± 1.49cd 32.41 ± 0.51 
Note: Superscripts “a” and “d” represent p < 0.01. Subscripts “b” and “c” denote p < 
0.001 and p < 0.05, respectively. 
3.7 Effect of matrix stiffening on the chemoresistance of encapsulated COLO-357 cells 
Figure 8 shows the effect of cyclic matrix stiffening/softening on growth of COLO-357 
cells under gemcitabine treatment (Fig. 8A). Live/dead staining results show that gemcitabine 
treatment only caused significant cell death in non-dynamic soft hydrogels (Fig. 8B) but not in 
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non-dynamic stiff hydrogels (Fig. 8C). In the dynamic ‘stiffened’ group, which mimics the effect 
of drug treatment in a stiffened stromal tissue, gemcitabine treatment caused limited amount of 
cell death (Fig. 8D). Finally, in the dynamic ‘softened’ group, which mimics the effect of 
softening a stiffened stromal tissue, gemcitabine treatment only led to some cell death (Fig. 8E) 
when compared with that in the non-dynamic soft hydrogels (Fig. 8B). AlamarBlue assay results 
mirrored the results in the live/dead staining images where only cells encapsulated in soft or 
softened hydrogels exhibited reduced metabolic activity upon gemcitabine addition, whereas 
cells in the stiffen or stiffened hydrogels were non-responsive to gemcitabine treatment (Fig. 
8F).  
4.   Discussion 
 Investigating the role of biophysical and biochemical cues on cell fate processes is 
highly challenging owing to the complex, heterogeneous, and dynamically changing nature of 
the ECM. Commercially available 3D culture platforms such as Matrigel® afford convenience, 
but lack well-defined or tunable properties. Additionally, static 3D hydrogels do not provide 
spatiotemporal control of matrix properties critical for guiding cell fate processes. Accumulating 
evidence suggests that matrix stiffness plays an integral role in cell mechanobiology. Therefore, 
designing ‘four-dimensional’ cell culture platforms are necessary for studying these phenomena. 
Our lab has utilized enzymatic strategies to dynamically control hydrogel crosslinking [23, 35, 
36].  We have also utilized SrtA-mediated transpeptidation to facilitate crosslinking of PEG-
peptide hydrogels [36]. While previous work has demonstrated the utility of SrtA in hydrogel 
crosslinking, degradation, and ligand immobilization [36, 53, 54, 60, 61], this unique reversible 
enzymatic reaction has not been explored for dynamically and reversibly modulating hydrogel 
crosslinking density.  
In this work, thiol-norbornene photoclick chemistry was used to prepare the PEG-peptide 
conjugates needed for investigating SrtA-induced hydrogel crosslinking (Fig. 1). A functional 
group substitution of ~70% was obtained for the PEG-GGGG conjugate. This could be a result 
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of peptide damage caused by extended UV irradiation and/or simply an inherent limitation in 
conjugation efficiency. If desired, these PEG-peptide conjugates may also be prepared using 
Michael-type addition between cysteine-bearing peptides and PEG-vinylsulfone or PEG-
maleimide. Nevertheless, we were able to use these PEG-peptide conjugates to form hydrogels 
with tunable gelation time (from minutes to hours) by simply adjusting enzyme concentration in 
the precursor solution. A relatively high concentrations of SrtA were required for rapid 
crosslinking of hydrogels in this study compared with previous results [53]. While this may be 
caused by lower substitution (~70%) of the PEG-peptide substrate, macromer functionality (e.g., 
8 in this study, compared with tens to hundreds in modified hyaluronic acid) may also be the 
reason of a reduced crosslinking efficiency. In addition to controlling network crosslinking, the 
reversible SrtA-mediated transpeptidation was also exploited to degrade PEG-peptide 
hydrogels, a strategy similar to that recently reported for complete gel dissolution [54]. Deferring 
from previous work where soluble glycine substrates were used in conjunction with SrtA, we 
discovered that adding SrtA alone could result in complete hydrogel degradation, albeit at a 
slower rate (i.e., several days) (Fig. 2C). During the exploration of degrading SrtA-crosslinked 
hydrogels, we could not obtain partially degraded hydrogels without simultaneously losing 
hydrogel mass. This was likely because all of the crosslinked peptide products (i.e., LPRTGGG) 
were substrates for SrtA (Fig. 1A). Gel mass loss (Fig. 2) was a direct result of losing PEG 
macromers, which occurred when all peptide products surrounding the macromer were cleaved. 
While this degradation method is beneficial for eroding hydrogel to recover cells or other 
encapsulated biologics, it is not ideal when only partial gel degradation (i.e., a loosened gel 
network without losing gel mass) is desired. To this end, we show that PEG-peptide hydrogels 
crosslinked by thiol-norbornene photopolymerization can be designed to exhibit a wide range of 
degradability without complete gel erosion (Fig. 3). These diverse degradation schemes were 
made possible by combining the step-growth and idealized hydrogel network structure with 
SrtA-sensitive and insensitive peptide linkers.  
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We utilized this hydrogel platform to investigate the effects of global gel softening on 
localized spreading of hMSCs. Our cell spreading results (Fig. 4) agree with that reported in the 
literature where soft hydrogels (>1 kPa) promoted spreading of hMSCs than stiff gels [62]. It is 
worth noting that while MMP-labile linkages are sensitive to local cellular activity, local MMP-
mediated degradation was not sufficient to degrade the entire hydrogel. On the other hand, SrtA 
was added exogenously, which led to softening of the hydrogels. Furthermore, since only 40% 
of the peptide crosslinks contained SrtA-sensitive sequence, the gels could be softened to a 
desired stiffness for evaluating the effect of temporal matrix softening on hMSCs spreading. 
 The reversibility of SrtA-mediated transpeptidation was also leveraged to fabricate 
hydrogels with dynamic matrix stiffening (Figs. 5 to 8). Notably, we achieved this by 
synthesizing a simple linear peptide crosslinker flanked with sequences of the two SrtA 
substrates at either end of the peptide. Once crosslinked into hydrogels, the pendant SrtA 
substrates (i.e., LPRTG and GGG) could be covalently ligated in the presence of SrtA, creating 
secondary crosslinks (i.e., LPRT-GGGG) and thus increasing gel crosslinking density (Fig. 5B 
and 5C). The stiffened gel could be subsequently softened by incubating the same gel with 
additional SrtA and a soluble glycine substrate (Fig. 5D). We experimentally determined that at 
least 3 hours of incubation was necessary for complete stiffening as a maximum degree of 
stiffening was observed at that time. Of note, an excess of oligoglycine substrate was used to 
drive the reaction towards complete transpeptidation [58, 63]. SrtA-mediated hydrolytic 
degradation can also be utilized to achieve gradual softening of the stiffened hydrogels without 
adding soluble glycine (Fig. 5E). This process was irreversible as the product LPRT-OH is not a 
substrate for SrtA. Furthermore, the degradation rate of hydrolysis-based gel degradation was 
drastically slower than transpeptidation-mediated degradation. Most importantly, multiple cycles 
of physiologically relevant degree of stiffening and softening could be reversibly achieved 
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through the same enzymatic reaction (Fig. 6) and without the need for using specialized 
macromers or potentially cytotoxic stimuli (e.g., UV light).  
A pancreatic cancer cell (PCC) line COLO-357 was used in this study to illustrate the 
effect of dynamic matrix properties on the growth and chemo-resistance of tumor spheroids. A 
PCC line was chosen due to its association with a dense stroma that is scant with vasculature 
[1]. Here, we exposed the cell-laden hydrogels to SrtA alone to induce gel stiffening (Figs. 5 
and 6). These additional peptide crosslinks were subsequently resolved with the use of SrtA and 
excess soluble glycinamide (Fig. 6). Cells grown in non-dynamic soft hydrogels exhibited 
continuous growth owing to the lower crosslinking and deformation of the network during 
spheroid growth (Figs. 7B, 7C, and 7E). After additional crosslinking of the pendant SrtA 
substrates, spheroid growth was reduced and exhibited characteristics similar to that in the non-
dynamic stiff gels (Figs. 7B, 7D, and 7E). Of note, the density of the spheroids in the hydrogels 
appears to increase with stiffening, which was caused by stiffening-induced volumetric 
shrinkage of the hydrogel. Additional on-demand softening on day 14 ‘loosened’ the hydrogel 
network, thus permitting further spheroid growth and reducing the apparent spheroid density 
(Figs. 7B, 7C, and 7E). Here, spheroid diameter was used as a metric to evaluate the effect of 
dynamic hydrogel crosslinking on the growth of cancer spheroids. Our results are consistent 
with previous observations suggesting that proliferation of COLO-357 spheroids is affected by 
hydrogel crosslinking [64]. Dynamic matrix stiffening also influenced the viability and 
proliferation of PCCs under gemcitabine treatment (Fig. 8). Whereas gemcitabine induced cell 
death and inhibited cellular metabolic activity in both the soft and softened hydrogels, cell 
deaths in the non-dynamic stiff and dynamically stiffened hydrogels were limited (Fig. 8D, 8E, 
and 8F). These results implied that PCCs could potentially evade drug treatment in a stiffened 
environment. One clinically relevant anti-PDAC therapy is to induce stromal tissue degradation 
while treating PCCs with chemotherapy [65]. Our results show that the majority of the cells 
encapsulated in the dynamically softened hydrogels remained alive following gemcitabine 
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treatment (Fig. 8C). This suggests that targeting stromal tissue by local matrix degradation may 
not be as effective as the cells would have been ‘de-sensitized’ to drug treatment after 
experiencing a period of stiffened matrix. More molecular characterizations are necessary to 
elucidate the mechanisms by which matrix mechanics regulate PCC behavior and drug 
sensitivity in 4D. Furthermore, studies using tumor-associated matrices (i.e., hyaluronic acid) 
may also improve the clinical relevance of the material design. Nonetheless, through 
establishing a cyclic/reversible dynamic hydrogel platform, this work has broadened the utility of 
SrtA-mediated transpeptidation in biomedical applications.  
5.   Conclusion 
 In conclusion, we have established a dynamic cell culture platform via SrtA-mediated 
reversible transpeptidation. The highly specific enzymatic reaction permits predictable, tunable, 
and reversible modulation of matrix stiffness. We identified the critical parameters for achieving 
on-demand hydrogel stiffening and softening. These conditions were cytocompatible for stem 
and cancer cells, suggesting the potential of this system in biomedical applications. We 
demonstrated that softened matrices permitted spreading of hMSCs, whereas reversibly 
stiffening matrices conferred control of cell spheroid growth. Stiffening hydrogels also promoted 
drug resistance behaviors and upregulated expression of SHH and ANKRD1 in PCCs. Future 
work will focus on exploiting SrtA-mediated reversible stiffening for studying cancer invasion and 
dormancy as well as stem cell differentiation under spatiotemporally regulated matrix properties. 
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Figure captions 
Figure 1. (A) Schematic of reversible SrtA-transpeptidation reaction. SrtA cleaves amide bond 
between threonine and glycine residues of LPRTG substrate and forms a thioacyl intermediate. 
Nucleophilic oligoglycine or water resolve intermediate. Note that glycine-containing product, 
LPRT(G)n, can undergo multiple cycles of transpeptidation with additional incubation with SrtA 
and oligoglycine. (B) SrtA-mediated gelation of PEG-peptide hydrogels. SrtA was used to initiate 
crosslinking between PEG-peptide conjugates. Cysteine containing SrtA substrates (i.e., 
CLPRTG and GGGGC) were conjugated to PEG-NB in the presence of UV light and 
photoinitiator LAP. (C) Test tube tilt test to track timing of sol-gel transition using 6 wt% 
PEG8NB-peptide conjugates, RGGGG:LPRTG=2). Eosin-Y (1 mM, red dye) was added for image 
clarity. 
 
Figure 2. Effect of (A) SrtA and (B) glycinamide concentration on the transpeptidation 
degradation of PEG-peptide hydrogels (6 wt% PEG-peptide, RGGGG:LPRTG=2 with 48 mM 
glycinamide and 50 µM SrtA for (A) and (B), respectively. (C) Effect of SrtA concentration on the 
hydrolytic degradation of PEG-peptide hydrogels (6 wt%, RGGGG:LPRTG=2).  
 
Figure 3. (A) Schematic of SrtA-mediated peptide cleavage. (B) Effect of alanine:glycine 
composition on softening of PEG8NB-A-G gels (3.0 wt% PEGNB, 25μM SrtA, & 12mM 
GGGGC). (C) Effect of SrtA concentration on softening of PEG8NB-A-G gels (50%A:50%G, 3.0 
wt%, 12mM GGGGC). (D) Effect of initial PEG8NB concentration on softening of PEG8NB-A-G 
gels (50%A:50%G, 25μM SrtA, & 12mM GGGGC). (E) Effect of treatment time on softening 
(50%A:50%G, 3.0 wt%, 12mM, 25µM SrtA, and 12mM GGGGC). 
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Figure 4. (A) Representative confocal images of encapsulated hMSCs in statically stiff and 
softened hydrogels. At least three z-stacked images per gel (10 slices, 100 µm thick) were 
taken. (Scale: 200 µm). (B) Circularity and (C) average cell area measurements of hMSCs in the 
statically stiff and softened hydrogels on day 14 post-encapsulation. 
 
Figure 5. (A) Schematic of SrtA-mediated reversible stiffening. (B) Effect of incubation time on 
stiffening of PEG-peptide hydrogels (2.5 wt% PEGNB, 25 µM SrtA). (C) Effect of SrtA 
concentration on stiffening of PEG-peptide hydrogels (2.5 wt% PEGNB, 4 hr incubation time). 
(D) Effect of glycine concentration on softening of PEG-peptide hydrogels (2.5 wt% PEGNB, 25 
µM SrtA). (E) SrtA-mediated hydrolytic degradation of PEG-peptide hydrogels (2.5 wt% PEGNB, 
16 hour incubation). 
 
Figure 6. Cyclic stiffening and softening of PEG-peptide hydrogels (2.5 wt% PEGNB). 
Alternating stiffening and softening correspond to 4 hr. incubations with SrtA (25 µM) and SrtA 
with glycinamide (15 mM), respectively. 
 
Figure 7. (A) Timeline of alternate stiffening and softening of COLO-357-laden hydrogels. 
Hydrogels were stiffened on day 7 and softened on day 14. Time of confocal imaging is 
indicated by the open arrows. All imaging was completed prior to enzyme treatments (B) 
Representative confocal images of encapsulated COLO-357 cells in statically soft, stiff, and 
reversibly stiffened hydrogels. At least three z-stacked images per gel (10 slices, 100 µm thick) 
were taken. (Scale: 200 µm). Histogram of spheroids diameters for (C) non-dynamic soft, (D) 
non-dynamic stiff, and (E) reversibly stiffened and softened hydrogels (i.e., soft-stiff-soft). 
 
Figure 8.  (A) Timeline of gel stiffening (at D4) and softening (at D7), as well as three-day 
gemcitabine treatment (D10-D13). All imaging was completed prior to enzyme or drug 
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treatments. (B-E) Representative live/dead images of cell-laden non-dynamic soft (B), non-
dynamic stiff (C), stiffened (D), and softened (E) hydrogels with and without gemcitabine 
treatment. At least three z-stacked images per gel (10 slices, 100 µm thick) were taken. (Scale: 
200 µm). (F) Metabolic activity of encapsulated cells pre- (at D10) and post-gemcitabine 
treatment (at D13). Data represent Mean ± SEM (n=3, *p<0.05, **p<0.01).  
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Statement of Significance 
 
Cell-laden ‘dynamic’ hydrogels are typically designed to enable externally stimulated stiffening 
or softening of the hydrogel network. However, no enzymatic reaction has been used to 
reversibly control matrix crosslinking. The application of SrtA-mediated transpeptidation in 
crosslinking and post-gelation modification of biomimetic hydrogels is innovative because of the 
specificity of the reaction and reversible tunability of crosslinking kinetics. While SrtA has been 
previously used to crosslink and fully degrade hydrogels, matrix softening and reversible 
stiffening of cell-laden hydrogels has not been reported. By designing simple peptide substrates, 
this unique enzymatic reaction can be employed to form a primary network, to gradually soften 
hydrogels, or to reversibly stiffen hydrogels. As a result, this dynamic hydrogel platform can be 
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used to answer important matrix-related biological questions that are otherwise difficult to 
address. 
 
 
 
 
 
 
 
